Jennifer Buynitzky

Associate Director, Medical Communications & Publications, Alnylam Pharmaceuticals at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Jennifer Buynitzky's Colleagues at Alnylam Pharmaceuticals
Olga Kats

Senior Specialist, Quality Assurance

Contact Olga Kats

Lan Dang

Senior Scientist

Contact Lan Dang

Bridget Sherwin

Financial Reporting Manager

Contact Bridget Sherwin

Sheila Murphy

Sr. Manager, Supply Chain

Contact Sheila Murphy

Sylvia Tsengouras

Sr Manager, Clinical Supply Chain

Contact Sylvia Tsengouras

View All Jennifer Buynitzky's Colleagues
Jennifer Buynitzky's Contact Details
HQ
(617) 551-8200
Location
316 Huntington Avenue,Boston,Massachusetts,02115,United States
Company
Alnylam Pharmaceuticals
Jennifer Buynitzky's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Jennifer Buynitzky
Jennifer Buynitzky currently works for Alnylam Pharmaceuticals.
Jennifer Buynitzky's role at Alnylam Pharmaceuticals is Associate Director, Medical Communications & Publications, Alnylam Pharmaceuticals.
Jennifer Buynitzky's email address is ***@alnylam.com. To view Jennifer Buynitzky's full email address, please signup to ConnectPlex.
Jennifer Buynitzky works in the SaaS industry.
Jennifer Buynitzky's colleagues at Alnylam Pharmaceuticals are Veeravagu Murugaiah, Olga Kats, Lan Dang, Bridget Sherwin, Sheila Murphy, William Zedalis, Sylvia Tsengouras and others.
Jennifer Buynitzky's phone number is (617) 551-8200
See more information about Jennifer Buynitzky